SIGNAL: A Workflow for Analyzing SARS-CoV-2 Genomes
Author Information
Author(s): Nasir Jalees, M. G. DeGroote, Maguire Finlay, Smith Kendrick, Panousis Emily, Baker Sheridan, Aftanas Patryk, Raphenya Amogelang, Alcock Brian, Maan Hassaan, Knox Natalie, Banerjee Arinjay, Mossman Karen, Wang Bo, Simpson Jared, Kozak Robert, Mubareka Samira, McArthur Andrew
Primary Institution: McMaster University
Hypothesis
The SIGNAL workflow can efficiently process large volumes of SARS-CoV-2 sequencing data for rapid genomic surveillance.
Conclusion
SIGNAL is one of the fastest-performing analysis tools for SARS-CoV-2 sequencing, providing high accuracy and rapid results.
Supporting Evidence
- SIGNAL has been used as the standard Illumina workflow at the Public Health Agency of Canada.
- During the first wave of SARS-CoV-2 infections in Canada, SIGNAL was responsible for ∼50% of Ontario’s and ∼20% of Canada’s genome sequences shared internationally.
- SIGNAL demonstrated a 10-fold faster performance than the next fastest workflow with negligible differences in accuracy.
Takeaway
SIGNAL is a computer program that helps scientists quickly analyze a lot of data from virus tests to understand how the virus is changing.
Methodology
SIGNAL uses Snakemake to manage parallel tasks for processing sequencing data, generating outputs like consensus genomes and variant calls.
Limitations
SIGNAL is limited to Illumina paired short-read sequencing data and is highly specialized for SARS-CoV-2 assembly.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website